The PerkinElmer New Coronavirus Nucleic Acid Detection Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in human oropharyngeal and nasopharyngeal swab samples. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests, or by similarly qualified non-U.S. laboratories.
|Test Gene Region||ORF1ab & N|
|Sample Type||oropharyngeal swab, nasopharyngeal swab, bronchoalveolar lavage (BAL), sputum, plasma and serum|
|Sample Volume||400 µL|
|Limit of Detection||20 copies/mL (400 µL)|
Specify: No cross-reactivity with common respiratory tract pathogens and blood stream pathogens.
With about 11,000 employees serving over 150 countries, PerkinElmer is a $2.3 billion global leader committed to innovating for a healthier world. We are passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical solutions markets.
Our innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and scientific expertise, help customers gain earlier and more accurate insights to improve lives and the world around us.